Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials

Por Saad, Ziad, Hibar, Derrek, Fedgchin, Maggie, Popova, Vanina, Furey, Maura L, Singh, Jaskaran B, Kolb, Hartmuth, Drevets, Wayne C, Chen, Guang
Publicado no Int J Neuropsychopharmacol (2020)

Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind,...

Por Canuso, Carla M., Singh, Jaskaran B., Fedgchin, Maggie, Alphs, Larry, Lane, Rosanne, Lim, Pilar, Pinter, Christine, Hough, David, Sanacora, Gerard, Manji, Husseini, Drevets, Wayne C.
Publicado no Focus (Am Psychiatr Publ) (2019)

Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial

Por Daly, Ella J., Singh, Jaskaran B., Fedgchin, Maggie, Cooper, Kimberly, Lim, Pilar, Shelton, Richard C., Thase, Michael E., Winokur, Andrew, Van Nueten, Luc, Manji, Husseini, Drevets, Wayne C.
Publicado no JAMA Psychiatry (2017)

Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study

Por Morrison, Randall L., Fedgchin, Maggie, Singh, Jaskaran, Van Gerven, Joop, Zuiker, Rob, Lim, Kyoung Soo, van der Ark, Peter, Wajs, Ewa, Xi, Liwen, Zannikos, Peter, Drevets, Wayne C.
Publicado no Psychopharmacology (Berl) (2018)

The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study

Por van de Loo, Aurora J. A. E., Bervoets, Adriana C., Mooren, Loes, Bouwmeester, Noor H., Garssen, Johan, Zuiker, Rob, van Amerongen, Guido, van Gerven, Joop, Singh, Jaskaran, der Ark, Peter Van, Fedgchin, Maggie, Morrison, Randall, Wajs, Ewa, Verster, Joris C.
Publicado no Psychopharmacology (Berl) (2017)

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Co...

Por Fedgchin, Maggie, Trivedi, Madhukar, Daly, Ella J, Melkote, Rama, Lane, Rosanne, Lim, Pilar, Vitagliano, Dawn, Blier, Pierre, Fava, Maurizio, Liebowitz, Michael, Ravindran, Arun, Gaillard, Raphael, Ameele, Hans Van Den, Preskorn, Sheldon, Manji, Husseini, Hough, David, Drevets, Wayne C, Singh, Jaskaran B
Publicado no Int J Neuropsychopharmacol (2019)